Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

854
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
854
Distributions to Estimate Population Parameter01:26

Distributions to Estimate Population Parameter

5.2K
The accurate values of population parameters such as population proportion, population mean, and population standard deviation (or variance) are usually unknown. These are fixed values that can only be estimated from the data collected from the samples. The estimates of each of these parameters are sample proportion, the sample mean, and sample standard deviation (or variance). To obtain the values of these sample statistics, data are required that have particular distribution and central...
5.2K
Volume of Distribution01:20

Volume of Distribution

1.5K
The apparent volume of distribution (Vd) is a crucial pharmacokinetic parameter representing the hypothetical body fluid volume into which a drug disperses. It is calculated based on the total amount of drug in the body (estimated from the administered dose and bioavailability) divided by the plasma drug concentration. The total amount of drug in the body does not directly refer to the dose given but is derived by accounting for absorption, distribution, metabolism, and excretion processes.
1.5K
Sample Proportion and Population Proportion01:20

Sample Proportion and Population Proportion

6.9K
Collecting samples or responses from an entire population takes significant time and effort, so a researcher collects responses from only a sample of that population. Suppose a study needs to collect information about a specific mobile application. After sample collection, the researcher analyzes the data and discovers that most individuals in the sample use that specific mobile application. The sample proportion measures the number of individuals in a sample who either use or don't use the...
6.9K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

299
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
299
Modeling and Similitude01:12

Modeling and Similitude

682
Scaled modeling is a fundamental technique in engineering, enabling the study of large and complex systems by creating smaller, manageable replicas that recreate critical characteristics of the original. In hydrology and civil infrastructure, for example, scaled models of dams help analyze water flow, turbulence, and pressure. This method allows for accurate predictions of real-world behavior within a controlled environment, significantly reducing the cost and time involved in full-scale...
682

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Smart sensing the spectrum: cutting-edge biosensor and biomarker approaches for early autism detection.

Metabolic brain disease·2026
Same author

Proton therapy range uncertainty reduction using vendor-agnostic tissue characterization on a virtual photon-counting CT head scan.

Medical physics·2026
Same author

Optimizing energy settings in CdTe, CZT, and Si photon-counting CT for material separation and detection.

Physics in medicine and biology·2026
Same author

Precise Lung Density Quantification with a Physics-based CT Harmonizer.

Radiology. Cardiothoracic imaging·2026
Same author

Utility of the virtual imaging trials methodology for objective characterization of AI systems and training data.

Journal of medical imaging (Bellingham, Wash.)·2026
Same author

RLIP76: a versatile ATP-dependent transporter as a pharmacotherapeutic target for epilepsy management.

Inflammopharmacology·2026

Related Experiment Video

Updated: Feb 27, 2026

Perceptual and Category Processing of the Uncanny Valley Hypothesis' Dimension of Human Likeness: Some Methodological Issues
07:34

Perceptual and Category Processing of the Uncanny Valley Hypothesis' Dimension of Human Likeness: Some Methodological Issues

Published on: June 3, 2013

18.0K

Demographic distribution matching between real-world and virtual phantom population.

Dhrubajyoti Ghosh1, Fakrul Tushar2, Lavsen Dahal2

  • 1Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina, USA.

Medical Physics
|February 26, 2026
PubMed
Summary
This summary is machine-generated.

DISTINCT, a new framework, aligns virtual and real patient data for imaging trials. This ensures accurate performance assessments across diverse populations, improving virtual imaging trial reliability.

Keywords:
Wasserstein distancedemographics matchingvirtual clinical trials

More Related Videos

Multimodal 3D Printing of Phantoms to Simulate Biological Tissue
05:11

Multimodal 3D Printing of Phantoms to Simulate Biological Tissue

Published on: January 11, 2020

8.1K
Creating Virtual-hand and Virtual-face Illusions to Investigate Self-representation
06:53

Creating Virtual-hand and Virtual-face Illusions to Investigate Self-representation

Published on: March 1, 2017

13.9K

Related Experiment Videos

Last Updated: Feb 27, 2026

Perceptual and Category Processing of the Uncanny Valley Hypothesis' Dimension of Human Likeness: Some Methodological Issues
07:34

Perceptual and Category Processing of the Uncanny Valley Hypothesis' Dimension of Human Likeness: Some Methodological Issues

Published on: June 3, 2013

18.0K
Multimodal 3D Printing of Phantoms to Simulate Biological Tissue
05:11

Multimodal 3D Printing of Phantoms to Simulate Biological Tissue

Published on: January 11, 2020

8.1K
Creating Virtual-hand and Virtual-face Illusions to Investigate Self-representation
06:53

Creating Virtual-hand and Virtual-face Illusions to Investigate Self-representation

Published on: March 1, 2017

13.9K

Area of Science:

  • Medical Imaging
  • Biostatistics
  • Clinical Trials

Background:

  • Virtual imaging trials (VITs) offer cost-effective alternatives to traditional clinical trials.
  • Demographic disparities between virtual and real cohorts can bias imaging performance assessments.
  • Unaddressed biases limit the translational relevance of VIT findings for diverse patient groups.

Purpose of the Study:

  • Introduce DISTINCT (Distributional Subsampling for Covariate-Targeted Alignment), a statistical framework for aligning demographic subsamples from clinical datasets with virtual cohorts.
  • Enable robust comparisons between virtual imaging trial populations and real-world clinical data.

Main Methods:

  • Applied DISTINCT to the National Lung Screening Trial (NLST) and a virtual dataset (VLST).
  • Jointly aligned continuous (age, BMI) and categorical (sex, race, ethnicity) variables using multidimensional bins.
  • Evaluated demographic similarity using Wasserstein and Kolmogorov-Smirnov distances.
  • Assessed lung cancer risk prediction performance and stability using ROC analysis on aligned subsamples.

Main Results:

  • DISTINCT identified a maximal demographically aligned NLST subsample of 9974 participants matching the VLST population.
  • Area under the curve (AUC) estimates for lung cancer risk scores stabilized around 6000 participants.
  • Stratified analyses highlighted demographic-specific variations in AUC, emphasizing the need for covariate alignment.

Conclusions:

  • DISTINCT offers a statistically rigorous and scalable method for covariate alignment between real and virtual imaging cohorts.
  • The framework is applicable to various imaging modalities, diseases, and factors of variability.
  • DISTINCT facilitates fair and representative performance assessments, advancing VIT integration in research and protocol optimization.